Thrombin Receptor (Protease Activated Receptor-1) Antagonists as Potent Antithrombotic Agents with Strong Antiplatelet Effects-Reference-Cited by-同舟云学术

Thrombin Receptor (Protease Activated Receptor-1) Antagonists as Potent Antithrombotic Agents with Strong Antiplatelet Effects

Published:2006-08-31 Issue:18 Volume:49 Page:5389-5403
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chackalamannil Samuel¹

Affiliation:

1. Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0603670

Reference203 articles.

1. Atlas of Heart Disease and Stroke; World Health Organization: Geneva, Switzerland, 2004.

2. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease

3. Health, United States, 2005, with Chartbook on Trends in the Health ofAmericans; National Center for Health Statistics: Hyattsville, MD, 2005; p 178.

4. European Cardiovascular Disease Statistics, 2000 Edition; British Heart Foundation: Oxford, U.K., 2000.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic management of ischemic stroke;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-15

2. Emerging roles of protease-activated receptors in cardiometabolic disorders;Journal of Cardiology;2023-04

3. Clinical pharmacology of antiplatelet drugs;Expert Review of Clinical Pharmacology;2022-09-11

4. Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies;Journal of Tissue Engineering;2022-01

5. Rapid hemostasis and high bioactivity cerium‐containing mesoporous bioglass for hemostatic materials;Journal of Biomedical Materials Research Part B: Applied Biomaterials;2021-12-15